Patient's Perspective on Psychiatric Drugs: A Multicenter Survey-Based Study.

OBJECTIVE We aimed to identify the expectations and preferences for medication and medical decision-making in patients with major psychiatric disorders. METHODS A survey was conducted among patients with major psychiatric disorders who visited psychiatric outpatient clinics at 15 hospitals between 2016 and 2018 in Korea. The survey consisted of 12 questions about demographic variables and opinions on their expectations for medication, important medical decision-makers, and preferred drug type. The most preferred value in each category in the total population was identified, and differences in the preference ratio of each item among the disease groups were compared. RESULTS A total of 707 participants were surveyed. In the total population, patients reported high efficacy (44.01%±21.44%) as the main wish for medication, themselves (37.39%±22.57%) and a doctor (35.27%±22.88%) as the main decision makers, and tablet/capsule (36.16%±30.69%) as the preferred type of drug. In the depressive disorders group, the preference ratio of high efficacy was significantly lower, and the preference ratio of a small amount was significantly higher than that of the psychotic disorder and bipolar disorder groups. The preference ratio of a doctor as an important decision maker in the bipolar disorder group was higher compared to the other groups. CONCLUSION This study revealed the preference for medications and showed differences among patients with psychiatric disorders. Providing personalized medicine that considers a patient's preference for the drug may contribute to the improvement of drug compliance and outcomes.

[1]  J. de Leon,et al.  Adherence to psychiatric medications: Comparing patients with schizophrenia, bipolar disorder and major depression. , 2021, Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology.

[2]  M. Mathews,et al.  Patients’ Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire , 2020, Patient preference and adherence.

[3]  P. Talbot,et al.  Medication nonadherence in bipolar disorder: a narrative review , 2018, Therapeutic advances in psychopharmacology.

[4]  P. Weiden,et al.  Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia , 2018, BMC Psychiatry.

[5]  P. Aslani,et al.  Consumer-related factors influencing antidepressant adherence in unipolar depression: a qualitative study , 2018, Patient preference and adherence.

[6]  W. Peñate,et al.  To what extent is treatment adherence of psychiatric patients influenced by their participation in shared decision making? , 2014, Patient preference and adherence.

[7]  J. Casoy,et al.  Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia , 2013, Patient preference and adherence.

[8]  T. Youn,et al.  The Preference Survey for Long-Acting Injectable Antipsychotics of Community-Dwelling Patients with Schizophrenia and their Caregivers , 2013 .

[9]  M. Sajatovic,et al.  Medication treatment perceptions, concerns and expectations among depressed individuals with Type I Bipolar Disorder. , 2009, Journal of affective disorders.

[10]  R. Drake,et al.  Shared decision-making preferences of people with severe mental illness. , 2007, Psychiatric services.

[11]  F. Johnson,et al.  Factors That Affect Adherence to Bipolar Disorder Treatments: A Stated-Preference Approach , 2007, Medical care.

[12]  G. Thornicroft,et al.  Medication adherence in schizophrenia: exploring patients', carers' and professionals' views. , 2005, Schizophrenia bulletin.

[13]  S. De Geest,et al.  Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[14]  Christian R. Dolder,et al.  Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. , 2002, The Journal of clinical psychiatry.

[15]  R. Rosenheck,et al.  Compliance with medication regimens for mental and physical disorders. , 1998, Psychiatric services.

[16]  K. Demyttenaere Compliance during treatment with antidepressants. , 1997, Journal of affective disorders.

[17]  R S Woodward,et al.  The effect of prescribed daily dose frequency on patient medication compliance. , 1990, Archives of internal medicine.

[18]  Mitchell K. Byrne,et al.  Treatment Adherence , 2021, Encyclopedia of Autism Spectrum Disorders.

[19]  Kristin Decker Diagnostic And Statistical Manual Of Mental Disorders Dsm 5 5th Edition , 2016 .

[20]  Moon-Soo Lee,et al.  Treatment compliance of antidepressants , 2010 .

[21]  Anuja Roy,et al.  Medication compliance and persistence: terminology and definitions. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.